HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: a preliminary anti- Alzheimer's study.

AbstractBACKGROUND:
Cholinesterase inhibition is a vital target for the development of novel and mechanism based inhibitors, owing to their role in the breakdown of acetylcholine (ACh) neurotransmitter to treat various neurological disorders including Alzheimer's disease (AD). Similarly, free radicals are implicated in the progression of various diseases like neurodegenerative disorders. Due to lipid solubility and potential to easily cross blood brain barrier, this study was designed to investigate the anticholinesterase and antioxidant potentials of the standardized essential oils from the leaves and flowers of Polygonum hydropiper.
METHODS:
Essential oils from the leaves (Ph.LO) and flowers (Ph.FO) of P. hdropiper were isolated using Clevenger apparatus. Oil samples were analyzed by GC-MS to identify major components and to attribute the antioxidant and anticholinesterase activity to specific components. Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory potentials of the samples were determined following Ellman's assay. Antioxidant assays were performed using 1,1-diphenyl,2-picrylhydrazyl (DPPH), 2,2-azinobis[3-ethylbenzthiazoline]-6-sulfonic acid (ABTS) and hydrogen peroxide (H2O2) free radical scavenging assays.
RESULTS:
In the GC-MS analysis 141 and 122 compounds were indentified in Ph.LO and Ph.FO respectively. Caryophylene oxide (41.42 %) was the major component in Ph.FO while decahydronaphthalene (38.29 %) was prominent in Ph.LO. In AChE inhibition, Ph.LO and Ph.FO exhibited 87.00** and 79.66***% inhibitions at 1000 μg/ml with IC50 of 120 and 220 μg/ml respectively. The IC50 value for galanthamine was 15 μg/ml. In BChE inhibitory assay, Ph.LO and Ph.FO caused 82.66*** (IC50 130 μg/ml) and 77.50***% (IC50 225 μg/ml) inhibitions respectively at 1000 μg/ml concentration. In DPPH free radical scavenging assay, Ph.LO and Ph.FO exhibited IC50 of 20 and 200 μg/ml respectively. The calculated IC50s were 180 & 60 μg/ml for Ph.LO, and 45 & 50 μg/ml for Ph.FO in scavenging of ABTS and H2O2 free radicals respectively.
CONCLUSIONS:
In the current study, essential oils from leaves and flowers of P. hydropiper exhibited dose dependent anticholinesterase and antioxidant activities. Leaves essential oil were more effective and can be subjected to further in-vitro and in-vivo anti-Alzheimer's studies.
AuthorsMuhammad Ayaz, Muhammad Junaid, Farhat Ullah, Abdul Sadiq, Mir Azam Khan, Waqar Ahmad, Muhammad Raza Shah, Muhammad Imran, Sajjad Ahmad
JournalLipids in health and disease (Lipids Health Dis) Vol. 14 Pg. 141 (Nov 04 2015) ISSN: 1476-511X [Electronic] England
PMID26530857 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Benzothiazoles
  • Biphenyl Compounds
  • Cholinesterase Inhibitors
  • Free Radical Scavengers
  • Oils, Volatile
  • Picrates
  • Plant Extracts
  • Sulfonic Acids
  • 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid
  • Hydrogen Peroxide
  • 1,1-diphenyl-2-picrylhydrazyl
  • Acetylcholinesterase
  • Butyrylcholinesterase
Topics
  • Acetylcholinesterase (chemistry, isolation & purification)
  • Animals
  • Benzothiazoles (antagonists & inhibitors, chemistry)
  • Biphenyl Compounds (antagonists & inhibitors, chemistry)
  • Butyrylcholinesterase (chemistry, isolation & purification)
  • Cholinesterase Inhibitors (chemistry, isolation & purification)
  • Electrophorus
  • Enzyme Assays
  • Flowers (chemistry)
  • Free Radical Scavengers (chemistry, isolation & purification)
  • Gas Chromatography-Mass Spectrometry
  • Horses
  • Hydrogen Peroxide (chemistry)
  • Oils, Volatile (chemistry, isolation & purification)
  • Picrates (antagonists & inhibitors, chemistry)
  • Plant Extracts (chemistry)
  • Plant Leaves (chemistry)
  • Polygonum (chemistry)
  • Sulfonic Acids (antagonists & inhibitors, chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: